An enzyme-based assay for the detection of acetaldehyde-protein adducts

NIH RePORTER · NIH · R43 · $272,137 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Chronic alcohol consumption is a significant issue worldwide which can lead to addiction and damage throughout the body. The first step in alcohol metabolism is its conversion into acetaldehyde, which is a highly reactive and toxic molecule. The formation of acetaldehyde adducts with protein and DNA is a primary mechanism of ethanol toxicity. Acetaldehyde adducts are a direct biomarker for alcohol abuse. We intend to develop a facile and rapid enzyme-based assay for measuring acetaldehyde-protein adducts to assess alcohol use and alcohol-related health consequences.

Key facts

NIH application ID
10760201
Project number
1R43AA030937-01A1
Recipient
REVEL PHARMACEUTICALS INC.
Principal Investigator
Kevin K Desai
Activity code
R43
Funding institute
NIH
Fiscal year
2023
Award amount
$272,137
Award type
1
Project period
2023-08-01 → 2024-07-31